Evidence map›Paper›PMID 41711854›Full record

ArticleAnalytical and bioanalytical chemistry2026

Optimization of LC-ExD methods for glycopeptides on an Omnitrap-Orbitrap platform.

Margaret Downs, Chaoshuang Xia, Cheng Lin, Joseph Zaia

Abstract read
PubMed Publisher
In one paragraph

Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Margaret DownsDepartment of Biochemistry & Cell Biology, Chobanian and Avedisian School of Medicine, Boston University Medical Campus, 670 Albany St., Rm. 509, Boston, 02118, USA.
Chaoshuang XiaDepartment of Biochemistry & Cell Biology, Chobanian and Avedisian School of Medicine, Boston University Medical Campus, 670 Albany St., Rm. 509, Boston, 02118, USA.
Cheng LinDepartment of Biochemistry & Cell Biology, Chobanian and Avedisian School of Medicine, Boston University Medical Campus, 670 Albany St., Rm. 509, Boston, 02118, USA.
Joseph ZaiaDepartment of Biochemistry & Cell Biology, Chobanian and Avedisian School of Medicine, Boston University Medical Campus, 670 Albany St., Rm. 509, Boston, 02118, USA. jzaia@bu.edu.ORCID http://orcid.org/0000-0001-9497-8701

Funding

national institutes for health R01AG075876national institutes for health R35GM144090
6 · The paper itself

Abstract

Glycoproteomics presents a challenge for analysis by conventional proteomics methods due to the size, complexity, and heterogeneity of glycans. Many published methods use higher-energy collisional dissociation (HCD) that preferentially fragments the glycan, preventing its confident localization on the peptide due to low abundances of peptide backbone fragmentation. However, the glycan fragment ions resulting from collisional dissociation have limited value for determining glycan topologies in part due to rearrangements that occur to protonated glycan groups during vibrational excitation. To overcome this problem, we investigated the use of electron-activated dissociation (ExD) methods that preferentially dissociate the peptide with low levels of vibrational excitation. Hot electron capture dissociation (hECD) has previously been demonstrated for glycosylated peptides using a Fourier-transform ion cyclotron resonance mass spectrometer, but its slower scan speed and lower sensitivity make it ineffective for larger-scale glycoproteomics studies. In this work, we employed an Omnitrap platform integrated with a Q Exactive-class mass spectrometer to perform hECD with enhanced speed and sensitivity. We evaluated a set of higher energy (he) ExD conditions and observed useful glycan fragmentation, including the cross-ring cleavages that define glycan topologies. Using this approach, we detected isomeric glycopeptides differing in glycan topology or glycosylation sites, highlighting the power of on-line LC-MS heExD analysis.

Indexed as

GlycopeptidesLiquid Chromatography-Mass SpectrometryMass SpectrometryProteomicsChromatography, LiquidGlycosylationPolysaccharidesTandem Mass SpectrometryGlycopeptidesPolysaccharidesElectron-activated dissociationGlycopeptideGlycoproteomicsGlycosylationMass spectrometry/ICP-MSProteoglycan

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.